Detalhe da pesquisa
1.
Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaques.
Mol Ther
; 21(2): 291-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23089733